Abstract: The invention relates to psychoneurology, more particularly to a method for treating multiple sclerosis that involves the use of a pharmaceutical composition containing 1,3-diethylbenzimidazole triiodide as the active compound. The composition (in solid or liquid form) for treating multiple sclerosis contains 1,3-diethylbenzimidazole triiodide and medicinal low-molecular polyvinylpyrrolidone and also, in the liquid form, ethyl alcohol in the following component ratio: liquid form—1.5-10.0 mass % 1,3-diethylbenzimidazole triiodide, 6.0-30.0 mass % medicinal low-molecular polyvinylpyrrolidone and 60.0-92.5 mass % 95% ethyl alcohol; solid form—10.0-25.0 mass % 1,3-diethylbenzimidazole triiodide and 75.0-90.0 mass % medicinal low-molecular polyvinylpyrrolidone.

Abstract: The invention relates to pharmacology and cosmetology, in particular, to a group of medications containing iodine in active form, and may be used to treat septic wounds of different etiology, and also to prevent evolution of skin tissue pathology under the effect of varied injurious factors, including cosmetology.

Abstract: The invention relates to medicine, veterinary, and cosmetology, in particular, to medications used to accelerate tissue regeneration processes, particularly in the presence of inflammatory processes attended by infection with pathogenic microflora, and may be used in pharmaceutics and cosmetology. The invention consists in 1,3-dialkylbenzimidazole halogenides exhibiting regenerative, anti-inflammatory, and antimicrobial activity of the general formula: wherein: R1 and R2=Alk, X?=F?, Cl?, Br?, J?.